Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicensePlus Black IconRevocationPlus Black IconReissuePlus Black IconCorrected translationPlus Black IconSPCPlus Black IconÁrgjöld

EP3445785

MANNAÐLÖGUÐ MÓTEFNI GEGN CLEVER-1 OG NOTKUN ÞEIRRA

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    18.4.2017
  • EP published:
    22.6.2022
  • EP application number:
    17722080.3
  • Max expiry date:
    17.4.2037
  • Expiry date:
    17.4.2026
  • Next due date:
    30.4.2026
  • Title in English:
    HUMANIZED ANTI CLEVER-1 ANTIBODIES AND THEIR USE
  • Language of the patent:
    English

Timeline

Today
18.4.2017EP application
22.6.2022EP Publication
9.9.2022Translation submitted
15.10.2022Registration published
17.4.2026Expires

Owner

  • Name:
    Faron Pharmaceuticals OY
  • Address:
    Joukahaisenkatu 6, 20520 Turku, FI

Inventor

  • Name:
    MAKSIMOW, Mikael
  • Address:
    20900 Turku, FI
  • Name:
    JALKANEN, Markku
  • Address:
    20760 Piispanristi, FI
  • Name:
    VAINIO, Marita
  • Address:
    20900 Turku, FI

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105, Reykjavík,

Priority

  • Number:
    20165335
  • Date:
    18.4.2016
  • Country:
    FI
  • Number:
    20165336
  • Date:
    18.4.2016
  • Country:
    FI

Classification

  • Categories:
    A61K 39/00, A61P 35/00, A61P 37/04, G01N 33/50, C07K 16/28

Annual fees

Number

Paid

Expires

Payer

Number: 7

Paid: 19.4.2023

Expires: 17.4.2024

Payer: CPA Global (Patrafee) AB

Number: 8

Paid: 19.4.2024

Expires: 17.4.2025

Payer: CPA Global (Patrafee) AB

Number: 9

Paid: 23.4.2025

Expires: 17.4.2026

Payer: CPA Global (Patrafee) AB

Upload documents